Search

CHENFIT-AMP is a novel nonlinear strategy that combines the fitting (gain prescription) and amplification (gain implementation) procedures for cochlear hearing loss. The fitting part of CHENFIT-AMP prescribes gain for outer hair cell (OHC) and inner hair cell (IHC) loss, respectively. The gain for OHC loss varies with the cochlear gain decided by the value of OHC loss and the input level. The gain for IHC loss varies with the value of IHC loss only and will be limited to a constant if there is a “dead region.” The amplification part of CHENFIT-AMP is responsible for estimating the input level and cochlear gain based on Chen's loudness model. CHENFIT-AMP is evaluated with four typical audiograms and nine individual audiograms. A widely used nonlinear fitting procedure, NAL-NL2, is evaluated to compare prescription results with CHENFIT-AMP; a standard nonlinear amplification algorithm, multichannel compression (MCC), with the parameters provided by NAL-NL2, is also evaluated to compare amplification results with CHENFIT-AMP. For long-term average speech spectrum (LTASS) inputs, CHENFIT-AMP generally prescribes similar gain as NAL-NL2 for the typical audiograms; however, gain prescribed by CHENFIT-AMP is more individualized than NAL-NL2 for the individual audiograms, especially when the audiograms have big deviations in the slope. For LTASS-shaped noise input, the gain implemented by MCC with parameters provided by NAL-NL2 cannot completely realize the gain prescribed by NAL-NL2. For speech sentence inputs, average ratings by subjects indicated that amplification by CHENFIT-AMP was preferred and led to a louder perception than that by MCC with parameters from NAL-NL2. [ABSTRACT FROM PUBLISHER]